Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Chemed Q4 2023 Adj EPS $6.60 Beats $6.25 Estimate, Sales $585.91M Miss $586.64M Estimate

Author: Benzinga Newsdesk | February 27, 2024 06:58pm
Chemed (NYSE:CHE) reported quarterly earnings of $6.60 per share which beat the analyst consensus estimate of $6.25 by 5.6 percent. The company reported quarterly sales of $585.91 million which missed the analyst consensus estimate of $586.64 million by 0.12 percent. This is a 7.18 percent increase over sales of $546.65 million the same period last year.

Posted In: CHE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist